There are limited studies on the prevalence of epilepsy and co-morbid conditions in older adults with an ID. To begin to address this prevalence of epilepsy was estimated for participants in the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing. Associations with demographic variables and co morbid health conditions were…

The aim of this study was to assess recurrence risk after a first remote symptomatic unprovoked seizure in childhood. All consecutive patients younger than 14 years with a first remote symptomatic unprovoked seizure who were seen at our hospital between 1994 and 2006 were included in the study and prospectively followed. Only two patients received…

Background: We examined the presence of medical conditions and medication use within a sample of adults with Down syndrome. Methods: Retrospective chart review using a sample of 141 adults with Down syndrome and age range of 30 to 65 years. Results: We identify 23 categories of commonly occurring medical conditions and 24 categories of medications…

It was found, among other things, that neither the presence of congenital heart disease, nor diabetes, nor intercurrent illness appeared to have any effect on the development of seizures. The age groups with the lowest proportion of EEG abnormalities were 25-34 years (48.7 percent abnormal) and 35-44 years (54.1 percent abnormal). (Author/DLS)

The aim of this study was to characterize the distribution, timing, and risk factors for psychiatric comorbidity in children with recent onset epilepsy. Children aged 8 to 18 years with recent onset epilepsy (less than 1 year in duration) of idiopathic etiology (n=53) and a healthy comparison group (n=50) underwent a structured psychiatric…

A study of the prevalence of and factors (sex, age, race, residence) relating to prescribed medications for profoundly mentally retarded students (N=92) in a Florida school district revealed that 53 percent received medication. Anticonvulsants, prescribed to 44.56 percent of the students, accounted for 74 percent of all medications. (CB)